CorMedix Inc.

US$5.32As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRMDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.52%)
Div yield —
ROE 54.93%
Biotechnology
Beta (5Y) 1.48
PE TTM 2.554
TSR TTM (52.20%)
Mkt cap US$414.7M
ROIC 55.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.44
21.00%
(98.33%)
Hold 12|6|8|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.09
0.09
17.31%
25.66%
24.06%
17.12%
Revenue$M
26.69
28.13
29.75
29.33
4.14%
8.81%
18.11%
13.66%
Peers (US$414.7M)
Cap (US$)
PE
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.589
0.114
0.112
EBIT/Intx
2.732
1.853
1.614
Own earn%
4.22
(54.17)
(58.13)
Sh yield%
21.66
39.80
38.99
Owners
Insiders/Inst%
1.16
80.08
Short interest%
4.35
SBC / revenue%
4.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
0–4
$1 testx
−0.2
Incr. ROIC%
17